19-51768878-T-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001005738.2(FPR2):​c.220T>C​(p.Phe74Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0059 in 1,614,192 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0044 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 33 hom. )

Consequence

FPR2
NM_001005738.2 missense

Scores

2
9
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.36

Publications

8 publications found
Variant links:
Genes affected
FPR2 (HGNC:3827): (formyl peptide receptor 2) Enables amyloid-beta binding activity; scavenger receptor binding activity; and signaling receptor activity. Involved in several processes, including cellular response to amyloid-beta; positive regulation of monocyte chemotaxis; and regulation of defense response. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
FPR1 (HGNC:3826): (formyl peptide receptor 1) This gene encodes a G protein-coupled receptor of mammalian phagocytic cells that is a member of the G-protein coupled receptor 1 family. The protein mediates the response of phagocytic cells to invasion of the host by microorganisms and is important in host defense and inflammation.[provided by RefSeq, Jul 2010]
FPR1 Gene-Disease associations (from GenCC):
  • susceptibility to localized juvenile periodontitis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009210765).
BP6
Variant 19-51768878-T-C is Benign according to our data. Variant chr19-51768878-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 781747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FPR2NM_001005738.2 linkc.220T>C p.Phe74Leu missense_variant Exon 2 of 2 ENST00000340023.7 NP_001005738.1 P25090A0A024R4P3
FPR2NM_001462.3 linkc.220T>C p.Phe74Leu missense_variant Exon 2 of 2 NP_001453.1 P25090A0A024R4P3
FPR2XM_006723120.4 linkc.220T>C p.Phe74Leu missense_variant Exon 3 of 3 XP_006723183.1 P25090A0A024R4P3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FPR2ENST00000340023.7 linkc.220T>C p.Phe74Leu missense_variant Exon 2 of 2 1 NM_001005738.2 ENSP00000340191.4 P25090

Frequencies

GnomAD3 genomes
AF:
0.00438
AC:
666
AN:
152180
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00590
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00468
AC:
1177
AN:
251488
AF XY:
0.00451
show subpopulations
Gnomad AFR exome
AF:
0.000923
Gnomad AMR exome
AF:
0.00119
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0149
Gnomad NFE exome
AF:
0.00662
Gnomad OTH exome
AF:
0.00407
GnomAD4 exome
AF:
0.00606
AC:
8860
AN:
1461894
Hom.:
33
Cov.:
31
AF XY:
0.00576
AC XY:
4190
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33480
American (AMR)
AF:
0.00127
AC:
57
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00153
AC:
40
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.0143
AC:
765
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00688
AC:
7652
AN:
1112012
Other (OTH)
AF:
0.00525
AC:
317
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
625
1251
1876
2502
3127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00437
AC:
666
AN:
152298
Hom.:
2
Cov.:
32
AF XY:
0.00463
AC XY:
345
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41574
American (AMR)
AF:
0.00183
AC:
28
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0170
AC:
181
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00590
AC:
401
AN:
68014
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
33
67
100
134
167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00518
Hom.:
4
Bravo
AF:
0.00330
TwinsUK
AF:
0.00917
AC:
34
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00616
AC:
53
ExAC
AF:
0.00474
AC:
576
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00540
EpiControl
AF:
0.00528

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FPR2: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.36
.;T;.;T;T;.
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.93
D;.;T;.;T;D
MetaRNN
Benign
0.0092
T;T;T;T;T;T
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Uncertain
2.4
.;M;.;M;M;.
PhyloP100
7.4
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-5.9
.;D;.;.;.;.
REVEL
Uncertain
0.46
Sift
Uncertain
0.0030
.;D;.;.;.;.
Sift4G
Benign
0.095
T;D;T;D;D;T
Polyphen
0.90
.;P;.;P;P;.
Vest4
0.39, 0.40
MutPred
0.72
Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);Loss of catalytic residue at F74 (P = 0.0415);
MVP
0.81
MPC
1.1
ClinPred
0.070
T
GERP RS
3.6
Varity_R
0.87
gMVP
0.38
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74602258; hg19: chr19-52272131; COSMIC: COSV60672754; API